H.C. Wainwright raised the firm’s price target on Optinose (OPTN) to $18 from $5 and keeps a Buy rating on the shares based on the announced 1-for-15 reverse stock split.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPTN: